Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding AG    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société ROCHE HOLDING AG
01/21ROCHE : FDA grants priority review to Roche's Esbriet (pirfenidone) for unclassi..
PU
01/21ROCHE : FDA Grants Priority Review to Genentech's Esbriet (pirfenidone) for Uncl..
BU
01/19CHUGAI PHARMACEUTICAL : Supports the Japan Climate Initiative's Calling to Raise..
AQ
01/18ROCHE ANNUAL GENERAL MEETING 2021 : Exercising of shareholder rights via the ind..
AQ
01/13CHUGAI PHARMACEUTICAL : Conducts Digital Transformation in Manufacturing with IB..
AQ
01/12ROCHE : confirms US government agreement to purchase additional doses of Regener..
AQ
01/12ROCHE : CHEPLAPHARM acquires the rights to Rivotril
AQ
01/12ROCHE : to present updated data confirming Tecentriq in combination with Avastin..
AQ
01/11ROCHE : Xofluza approved by the European Commission for the treatment of influen..
AQ
01/11ROCHE : launches two digital pathology image analysis algorithms for precision p..
AQ
01/11ROCHE : Xofluza approved by the European Commission for the treatment of influen..
AQ
01/05ROCHE : Invitation to Roche's Full Year Results 2020 Presentation
PU
01/05GENENTECH : 's Novel Anti-TIGIT Tiragolumab Granted FDA Breakthrough Therapy Des..
BU
01/05ROCHE : novel anti-TIGIT tiragolumab granted FDA Breakthrough Therapy Designatio..
AQ
2020Chugai Obtains Approval for Expanded Use of FoundationOne CDx Cancer Genomic ..
AQ
2020HALOZYME THERAPEUTICS : Announces Roche Receives European Commission Approval fo..
AQ
2020CHUGAI PHARMACEUTICAL THE : Launch of Chugai's New TV Commercial Featuring Erika..
AQ
2020ROCHE : European Commission approves Roche's Phesgo (fixed-dose combination of P..
AQ
2020CHUGAI PHARMACEUTICAL : Osteoporosis Agent Edirol Obtains Regulatory Approval in..
AQ
2020ROCHE : faricimab meets primary endpoint and shows strong durability across two ..
AQ
2020GENENTECH : 's Faricimab Meets Primary Endpoint and Shows Strong Durability Acro..
BU
2020REGENERON PHARMACEUTICALS : New England Journal of Medicine Publishes Positive I..
AQ
2020ROCHE : Diagnostics to create Software Development Hub in Laval, Quebec
AQ
2020ROCHE : FDA Approves Genentech's Ocrevus Shorter 2-Hour Infusion for Relapsing a..
AQ
2020ROCHE : launches cobas PIK3CA Mutation Test for patients with advanced or metast..
AQ
2020ROCHE : FDA approves Roche's OCREVUS® (ocrelizumab) shorter 2-hour infusion for ..
AQ
2020ROCHE : FDA Approves Genentech's Ocrevus (ocrelizumab) Shorter 2-Hour Infusion f..
BU
2020CHUGAI PHARMACEUTICAL : in-licenses Antibody Cocktail for COVID-19 from Roche
AQ
2020ROCHE : launches laboratory SARS-CoV-2 antigen test to support high-volume testi..
AQ
2020ROCHE : presents exploratory data from the Phase III IMvigor010 study in early b..
AQ
2020ROCHE : UC Davis - The next generation of combined COVID-19 and flu test rolls o..
AQ
2020CURIS : Announces Positive Preliminary Data from Ongoing Phase 1 Study of CA-494..
AQ
2020ROCHE : New Roche antibody test to be used in Moderna COVID-19 vaccine trial
AQ
2020ROCHE : partners with Moderna to include SARS-CoV-2 antibody test in ongoing COV..
AQ
2020ROCHE : New follow-up phase III data reinforce the long-term benefit of Roche's ..
AQ
2020CURIS : Announces Updated Preliminary Data from Ongoing Phase 1 Study of CA-4948..
AQ
2020ROCHE : presents new data from its bispecific antibody portfolio across a range ..
AQ
2020ROCHE : announces new data reinforcing the long-term benefit of Venclexta/Vencly..
AQ
2020ROCHE : New data presented at ASH 2020 reinforces the benefit/risk profile of fi..
AQ
2020ROCHE : New follow-up phase III data reinforce the long-term benefit of Roche's ..
AQ
2020ROCHE : announces new data reinforcing the long-term benefit of Venclexta/Vencly..
AQ
2020GENENTECH : Announces New Data Reinforcing the Long-Term Benefit of Venclexta-Ba..
BU
2020ROCHE : Genentech Announces FDA Approval of Gavreto for People With Advanced or ..
AQ
2020ROCHE : announces FDA approval of Gavreto (pralsetinib) for people with advanced..
AQ
2020ROCHE : receives FDA Emergency Use Authorization for new test to measure the lev..
AQ
2020GENENTECH : Announces FDA Approval of Gavreto (pralsetinib) for People With Adva..
BU
2020ROCHE : FDA approves Xolair® (omalizumab) for adults with nasal polyps
AQ
2020GENENTECH : Announces FDA Approval of Xolair (omalizumab) for Adults with Nasal ..
BU
2020REMINDER : Invitation to Roche's virtual event on key hematology data presented ..
PU
2020Chugai Files Patent Infringement Lawsuit concerning Edirol Capsules
AQ
2020Chugai and DeNA Jointly Launch 'Ring Again,' a Rheumatoid Arthritis Disease A..
AQ
2020SHIONOGI : Announces FDA Approval of XOFLUZA for the prevention of Influenza fol..
AQ
2020ROCHE : Genentech Announces FDA Approval of Xofluza for the Prevention of Influe..
AQ
2020ROCHE : announces FDA approval of Xofluza for the prevention of influenza follow..
PU
2020ROCHE : announces FDA approval of Xofluza for the prevention of influenza follow..
PU
2020ROCHE : announces FDA approval of Xofluza for the prevention of influenza follow..
AQ
2020GENENTECH : Announces FDA Approval of Xofluza for the Prevention of Influenza Fo..
BU
2020ROCHE : Regeneron's REGN-COV2 is first antibody cocktail for COVID-19 to receive..
PU
2020CHUGAI PHARMACEUTICAL : Receives the Best IR Award
AQ
2020CHUGAI PHARMACEUTICAL : Selected for the First Time in the 'DJSI World,' a Globa..
AQ
2020SPARK THERAPEUTICS : Expands Visionary Leadership with Appointment of Michael Re..
AQ
2020DICERNA PHARMACEUTICALS : Announces Positive Updated Data from Phase 1 Trial of ..
AQ
2020ROCHE : Leading Diagnostics Companies Join Forces to Establish the Access to Com..
PR
2020ROCHE : CHMP recommends EU approval of Roche's Xofluza for the treatment of infl..
AQ
2020HALOZYME THERAPEUTICS : Announces CHMP Recommends EU Approval of Roche's Phesgo ..
AQ
2020ROCHE : Spark Therapeutics Expands Visionary Leadership with Appointment of Mich..
AQ
2020ROCHE : CHMP recommends EU approval of Roche's Xofluza® (baloxavir marboxil) for..
AQ
2020ROCHE : ranked the most sustainable healthcare company in the Dow Jones Sustaina..
AQ
2020ROCHE : CHMP recommends EU approval of Roche's Xofluza® (baloxavir marboxil) for..
PU
2020ROCHE : CHMP recommends EU approval of Roche's Xofluza® (baloxavir marboxil) for..
AQ
2020ROCHE : UC Davis - New cutting-edge rapid test detects both COVID-19 and flu
AQ
2020ROCHE : CHMP recommends EU approval of Roche's Phesgo (fixed-dose combination of..
PU
2020ROCHE : CHMP recommends EU approval of Roche's Phesgo (fixed-dose combination of..
AQ
2020CURIS : Announces Collaboration with the National Cancer Institute for the Devel..
AQ
2020CURIS : Reports Third Quarter 2020 Financial Results
AQ
1  2  3  4  5  6  7  8  9  10Next